74 filings
Page 3 of 4
8-K
y415sd9wnvmds3x4
14 Mar 22
Other Events
8:37am
8-K
vlrzt45s7ci4ntainfxk
1 Mar 22
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Pipeline and Business Progress
4:11pm
8-K
v77z c0yg
9 Feb 22
Other Events
4:10pm
8-K
keg6zp64x1
25 Jan 22
Departure of Directors or Certain Officers
8:01am
8-K
ocxhwn7 k4a64w
8 Nov 21
Phathom Pharmaceuticals Reports Third Quarter 2021 Results and Provides Key Clinical, Regulatory, and Business Updates
8:06am
8-K
xrzra1wle31spa10
18 Oct 21
Results of Operations and Financial Condition
7:06am
8-K
c2uemjfumxel
27 Sep 21
Other Events
8:08am
8-K
9um6fsfdan450s
20 Sep 21
Entry into a Material Definitive Agreement
8:06am
8-K
v1rfxb4 k8uwlz
8 Sep 21
Other Events
8:05am
8-K
da8qshf1p
10 Aug 21
Phathom Pharmaceuticals Reports Second Quarter 2021 Results and Provides Update Regarding Key Clinical and Regulatory Milestones
8:05am
8-K
yuo9bz 9d1yn
5 Aug 21
Other Events
7:35am
8-K
0gymkc0likzzb
8 Jul 21
Entry into a Material Definitive Agreement
4:01pm
8-K
u78w9 7cfj6
4 Jun 21
Departure of Directors or Certain Officers
4:05pm
8-K
snot4xo3ru664i69wh2
25 May 21
Departure of Directors or Certain Officers
4:15pm
8-K
b5gm6f88l2t
11 May 21
Phathom Pharmaceuticals Reports First Quarter 2021 Results and Provides Recent Business Updates
8:06am
8-K
80p4mkn6vut3bf
29 Apr 21
Other Events
4:18pm
8-K
1o7 2hsyn7
30 Mar 21
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2020
12:00am
8-K
ce978u
31 Dec 20
Entry into a Material Definitive Agreement
8:30am
8-K
hjqtf4m7
17 Dec 20
Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock
4:26pm
8-K
t23ueqhh8a7oiispm
14 Dec 20
Other Events
8:53am